Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Thalassemia and ASS1[original query] |
---|
Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/ß-thalassemia patients. Pharmacogenomics 2016 Feb . Chalikiopoulou Constantina, Tavianatou Anastasia-Gerasimoula, Sgourou Argyro, Kourakli Alexandra, Kelepouri Dimitra, Chrysanthakopoulou Maria, Kanelaki Vasiliki-Kaliopi, Mourdoukoutas Evangelos, Siamoglou Stavroula, John Anne, Symeonidis Argyris, Ali Bassam R, Katsila Theodora, Papachatzopoulou Adamantia, Patrinos George |
Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in ?-Thalassemia Intermedia: A Validation Cohort Study. Hemoglobin 2019 5 43 (1): 27-33. Kolliopoulou Alexandra, Siamoglou Stavroula, John Anne, Sgourou Argyro, Kourakli Alexandra, Symeonidis Argiris, Vlachaki Efthymia, Chalkia Panagiota, Theodoridou Stamatia, Ali Bassam R, Katsila Theodora, Patrinos George P, Papachatzopoulou Adamant |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: